Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
27 28 Next >
Amazon Considers Launching Ad-Supported Prime Video Tier, Google & Microsoft Face Backlash For Ad Inclusion In AI Trials, Airbus Records One-Third Jump In May Deliveries: Today's Top Stories
Tickers AMZN BLK DIS EADSY
Tags NVS TOSYY Market News
From Benzinga
Novartis' Sandoz Foresees Rapid Growth Post Spin-Off in Generics Market Amid Upcoming Patent Expirations
Tickers NVS
Tags News Guidance NVS
From Benzinga
Is Novartis a Good Stock to Buy Right Now?
Tickers NVS
Tags Recent Press Releases NVS Market News
From Motley Fool
Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays.
Tickers ABBV ALNY AMGN ARGX
Tags ALNY IBB GILD
From MarketWatch
Looking At Novartis's Recent Unusual Options Activity
Tickers NVS
Tags Options Markets Benzinga
From Benzinga
Avrobio Stock Jumps On Sale Of Gene Therapy Program To Novartis
Tickers AVRO NVS
Tags Penny Stocks Benzinga News
From Benzinga
Avrobio Offloads Gene Therapy Program For Rare Genetic Disorder To Novartis
Tickers AVRO NVS
Tags Benzinga General Penny Stocks
From Benzinga
Immix Biopharma's Subsidiary Says Investigational CAR T Therapy Shows 100% Response Rate In Amyloidosis
Tickers BGNE IMMX JNJ NVS
Tags Movers News Market News
From Benzinga
Why Is AVROBIO (AVRO) Stock Up 83% Today?
Tickers AVRO GHL MULN NVS
Tags MULN NVS AVRO
From InvestorPlace
You can’t rely on indexes to pick international stocks, this 5-star fund manager says. Here are 3 of his top selections.
Tickers BRK-B CHKP HDB NVS
Tags DHIIX HDB MX:FEMSAUBD
From MarketWatch
Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance
Tickers AZN BIIB KRTX NVS
Tags PFE NVS Market News
From Benzinga
What's Going On With Immix Biopharma Stock Today
Tickers BGNE IMMX MRK NVS
Tags Movers Health Care BGNE
From Benzinga
Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Tickers AMGN NVS
Tags Biotech Legal Large Cap
From Benzinga
Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine
Tickers GILD JNJ LEGN NVS
Tags General GILD NVS
From Benzinga
Is This Big Pharma Stock a Buy for Dividend Investors?
Tickers NVS
Tags NVS Recent Press Releases Market News
From Motley Fool
Rare Blood Disorder Treatment Breakthrough: Novartis' Candidate Improves Hemoglobin To Near-Normal Levels
Tickers NVS
Tags News NVS Health Care
From Benzinga
After Q1 Review, Novartis Narrows R&D Pipeline To Prioritize High-Value Transformative Medicines
Tickers NVS
Tags Briefs Biotech General
From Benzinga
3 Top Biotech Stocks Defying the Bear Market
Tickers BGNE BIIB LLY NVS
Tags Market News LLY NVS
From Motley Fool
Why Novartis Stock Is Trading Higher Today
Tickers NVS
Tags Biotech Briefs Benzinga
From Benzinga
Novartis raises 2023 view, after posting higher profit and sales
Tickers NVS
Tags CH:NOVN NVS
From MarketWatch
Earnings Preview: Novartis
Tickers NVS
Tags BZI/EP Earnings Market News
From Benzinga
Actinium Announces Positive Phase 3 Trial Results, NCI CRADA For AML Drug Candidates – Could They Become New Standards Of Care For This Deadly Disease?
Tickers KURA NVS PFE SNDX
Tags Benzinga General Biotech
From Benzinga
Novartis Says Relapsing Multiple Sclerosis Patients Remained Free From Disease Progression For Up Five Years With Kesimpta Treatment
Tickers NVS
Tags NVS Health Care Market News
From Benzinga
Why Shares of Legend Biotech Jumped Wednesday
Tickers BMY JNJ LEGN NVS
Tags Recent Press Releases NVS JNJ
From Motley Fool
New York Rep. Daniel Goldman Bought Over $50K Worth of Novartis Stock: Here's What You Should Know
Tickers NVS
Tags BZI/GT Trading Ideas News
From Benzinga
2 Best Biotech Stocks to Buy for the Long Haul
Tickers JNJ NVS
Tags Market News JNJ NVS
From Motley Fool
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
Tickers ALLR BIIB BMY CLOV
Tags Stocks to Sell NKTR BIIB
From InvestorPlace
Relay Therapeutics' Stock Price Premium Vs Peers Is Justified By Its Platform Technology, Analyst Says
Tickers NVS RLAY
Tags Price Target Analyst Ratings General
From Benzinga
Novartis Earnings Conference Call Is Coming Up, Here's What You Need To Know
Tickers NVS
Tags BZI/CONF NVS Benzinga
From Benzinga
Alzheimer's Disease Largely Remains A Mystery, With A Lack Of Highly Effective Treatments — Could Regulatory T-Cells (Tregs) Be The Answer?
Tickers COYA LLY NVS
Tags General Coya Therapeutics Benzinga
From Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.